Stocks and Investing Stocks and Investing
Thu, March 30, 2023
Wed, March 29, 2023
Tue, March 28, 2023
Mon, March 27, 2023

Judah Frommer Reiterated (ATAI) at Buy and Held Target at $9 on, Mar 27th, 2023


Published on 2024-10-28 02:26:08 - WOPRAI, Judah Frommer
  Print publication without navigation


Judah Frommer of Credit Suisse, Reiterated "Atai Life Sciences N.V." (ATAI) at Buy and Held Target at $9 on, Mar 27th, 2023.

Judah has made no other calls on ATAI in the last 4 months.



There are 2 other peers that have a rating on ATAI. Out of the 2 peers that are also analyzing ATAI, 0 agree with Judah's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Judah


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Thursday, January 19th, 2023
  • Neena Bitritto-Garg of "Citigroup" Maintained at Strong Buy with Decreased Target to $10 on, Monday, January 9th, 2023